Navigation Links
TNFerade in Medical News

GenVec Announces Second Quarter 2009 Results Conference Call

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...

GenVec Receives Grant for Malaria Vaccine Program

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...
TNFerade in Medical Technology

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

GAITHERSBURG, Md.--(BUSINESS WIRE)--Jun 4, 2007 - GenVec, Inc. (Nasdaq: GNVC) announced today that updated preliminary safety and efficacy data from the clinical development program of its lead product TNFerade(TM) was presented in a poster session on gastrointestinal cancers at the annual meeting ...

TNFerade(TM) Phase III Data Presented at ASCO

...ts) had occurred. The analysis concluded that tnferade appeared to be safe and well-tolerated. The analys...icated a 25% reduction in the risk of death in the tnferade plus standard-of-care (SOC) arm compared to the pa... within approximately 11.8 months. However, in the tnferade plus SOC group, 75% of the patients did not die un...

GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy

...e) is an adenovector, or DNA carrier, which contains the gene for TNF(alpha), a potent immune system protein with well-documented anti-cancer effects. tnferade is currently in a pivotal Phase II/III trial for locally advanced pancreatic cancer. GenVec researchers presented a poster entitled, "Selective deliv...
TNFerade in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

...by increases related to the manufacturing costs of tnferade arising from the letter agreement and subsequent t... Second Quarter and Recent Highlights tnferade for Cancer As of July 31, 2009, 262 ...tudy (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for...

GenVec Expands Contract Supporting Malaria Vaccine Program

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...

GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants

...peutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. tnferade has also been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal ca...
Other Tags
(Date:7/1/2015)... ... 2015 , ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. ... Symposium . Set for March 6th - 8th, the 2016 meeting will be held ... training and fundamentals of nasal surgery through the most modern advancements and updates in ...
(Date:7/1/2015)... ... July 01, 2015 , ... During the first week of ... Training and Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th ... brings together learning and development professionals from more than 300 life sciences companies ...
(Date:7/1/2015)... ... - (PRWEB) July 01, 2015 , ... Lisa Keys, the widow of U.S. ... 15-16th (MSG Keys’ birthday) in memory of her late husband and all of America’s ... of the Bronze Star Medal, died during a Special Forces training exercise in December ...
(Date:7/1/2015)... ... 2015 , ... “Well-meaning social policy often has unintended and ... School of International and Public Affairs. , The researchers examined longitudinal ... Survey on Drug Use and Health, which is a nationally representative survey of ...
(Date:7/1/2015)... ... July 01, 2015 , ... Scoliosis is a disorder in which the normally straight vertical line ... 2 to 3 percent of the population, or an estimated 6 to 9 million people. ... between the ages of 10 and 15. Most types of scoliosis are more common in ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces that its ... segment on "Money on the Mark", scheduled to air on ... June 20 th . The broadcast ... from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino ...
(Date:6/17/2015)... GARDENS, Fla. , June 17, 2015 /PRNewswire/ ... solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... casual sandwich chain, to increase security, improve accountability ... fingerprint readers enable instant, non-repudiable identity confirmation for ...
Breaking Biology News(10 mins):Body-Worn Temperature Sensors Market - Global Industry Analysis 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
Other Contents